Literature DB >> 17195841

Production of cattle lacking prion protein.

Jürgen A Richt1, Poothappillai Kasinathan, Amir N Hamir, Joaquin Castilla, Thillai Sathiyaseelan, Francisco Vargas, Janaki Sathiyaseelan, Hua Wu, Hiroaki Matsushita, Julie Koster, Shinichiro Kato, Isao Ishida, Claudio Soto, James M Robl, Yoshimi Kuroiwa.   

Abstract

Prion diseases are caused by propagation of misfolded forms of the normal cellular prion protein PrP(C), such as PrP(BSE) in bovine spongiform encephalopathy (BSE) in cattle and PrP(CJD) in Creutzfeldt-Jakob disease (CJD) in humans. Disruption of PrP(C) expression in mice, a species that does not naturally contract prion diseases, results in no apparent developmental abnormalities. However, the impact of ablating PrP(C) function in natural host species of prion diseases is unknown. Here we report the generation and characterization of PrP(C)-deficient cattle produced by a sequential gene-targeting system. At over 20 months of age, the cattle are clinically, physiologically, histopathologically, immunologically and reproductively normal. Brain tissue homogenates are resistant to prion propagation in vitro as assessed by protein misfolding cyclic amplification. PrP(C)-deficient cattle may be a useful model for prion research and could provide industrial bovine products free of prion proteins.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17195841      PMCID: PMC2813193          DOI: 10.1038/nbt1271

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


  36 in total

1.  Sleep and sleep regulation in normal and prion protein-deficient mice.

Authors:  I Tobler; T Deboer; M Fischer
Journal:  J Neurosci       Date:  1997-03-01       Impact factor: 6.167

2.  Expression of amino-terminally truncated PrP in the mouse leading to ataxia and specific cerebellar lesions.

Authors:  D Shmerling; I Hegyi; M Fischer; T Blättler; S Brandner; J Götz; T Rülicke; E Flechsig; A Cozzio; C von Mering; C Hangartner; A Aguzzi; C Weissmann
Journal:  Cell       Date:  1998-04-17       Impact factor: 41.582

3.  Mice devoid of prion protein have cognitive deficits that are rescued by reconstitution of PrP in neurons.

Authors:  José R Criado; Manuel Sánchez-Alavez; Bruno Conti; Jeannie L Giacchino; Derek N Wills; Steven J Henriksen; Richard Race; Jean C Manson; Bruce Chesebro; Michael B A Oldstone
Journal:  Neurobiol Dis       Date:  2005 Jun-Jul       Impact factor: 5.996

4.  T-lymphocyte activation and the cellular form of the prion protein.

Authors:  N A Mabbott; K L Brown; J Manson; M E Bruce
Journal:  Immunology       Date:  1997-10       Impact factor: 7.397

5.  Ataxia in prion protein (PrP)-deficient mice is associated with upregulation of the novel PrP-like protein doppel.

Authors:  R C Moore; I Y Lee; G L Silverman; P M Harrison; R Strome; C Heinrich; A Karunaratne; S H Pasternak; M A Chishti; Y Liang; P Mastrangelo; K Wang; A F Smit; S Katamine; G A Carlson; F E Cohen; S B Prusiner; D W Melton; P Tremblay; L E Hood; D Westaway
Journal:  J Mol Biol       Date:  1999-10-01       Impact factor: 5.469

6.  The normal cellular form of prion protein modulates T cell responses.

Authors:  John Bainbridge; Kenneth Barry Walker
Journal:  Immunol Lett       Date:  2005-01-15       Impact factor: 3.685

7.  In vitro generation of infectious scrapie prions.

Authors:  Joaquín Castilla; Paula Saá; Claudio Hetz; Claudio Soto
Journal:  Cell       Date:  2005-04-22       Impact factor: 41.582

Review 8.  Prions.

Authors:  S B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-10       Impact factor: 11.205

9.  Mice deficient for prion protein exhibit normal neuronal excitability and synaptic transmission in the hippocampus.

Authors:  P M Lledo; P Tremblay; S J DeArmond; S B Prusiner; R A Nicoll
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-19       Impact factor: 11.205

Review 10.  Prions and the blood and immune systems.

Authors:  Neil Mabbott; Marc Turner
Journal:  Haematologica       Date:  2005-04       Impact factor: 9.941

View more
  99 in total

Review 1.  Prions on the move.

Authors:  Charles Weissmann; Jiali Li; Sukhvir P Mahal; Shawn Browning
Journal:  EMBO Rep       Date:  2011-10-28       Impact factor: 8.807

2.  Germline modification of domestic animals.

Authors:  L Tang; R González; I Dobrinski
Journal:  Anim Reprod       Date:  2015 Jan-Mar       Impact factor: 1.807

3.  Manganese upregulates cellular prion protein and contributes to altered stabilization and proteolysis: relevance to role of metals in pathogenesis of prion disease.

Authors:  Christopher J Choi; Vellareddy Anantharam; Dustin P Martin; Eric M Nicholson; Jürgen A Richt; Arthi Kanthasamy; Anumantha G Kanthasamy
Journal:  Toxicol Sci       Date:  2010-02-22       Impact factor: 4.849

4.  Prion protein quantification in human cerebrospinal fluid as a tool for prion disease drug development.

Authors:  Sonia M Vallabh; Chloe K Nobuhara; Franc Llorens; Inga Zerr; Piero Parchi; Sabina Capellari; Eric Kuhn; Jacob Klickstein; Jiri G Safar; Flavia C Nery; Kathryn J Swoboda; Michael D Geschwind; Henrik Zetterberg; Steven E Arnold; Eric Vallabh Minikel; Stuart L Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-01       Impact factor: 11.205

Review 5.  A structural overview of the vertebrate prion proteins.

Authors:  Annalisa Pastore; Adriana Zagari
Journal:  Prion       Date:  2007-07-08       Impact factor: 3.931

6.  Longitudinal clinical, neuropsychological, and neuroimaging characterization of a kindred with a 12-octapeptide repeat insertion in PRNP: the next generation.

Authors:  Ryan A Townley; Angelina J Polsinelli; Julie A Fields; Mary M Machulda; David T Jones; Jonathan Graff-Radford; Kejal M Kantarci; Val J Lowe; Rosa V Rademakers; Matt C Baker; Neeraj Kumar; Bradley F Boeve
Journal:  Neurocase       Date:  2020-06-30       Impact factor: 0.881

7.  Prion gene paralogs are dispensable for early zebrafish development and have nonadditive roles in seizure susceptibility.

Authors:  Patricia L A Leighton; Richard Kanyo; Gavin J Neil; Niall M Pollock; W Ted Allison
Journal:  J Biol Chem       Date:  2018-06-14       Impact factor: 5.157

8.  Production of Prnp-/- goats by gene targeting in adult fibroblasts.

Authors:  Caihong Zhu; Bei Li; Guohua Yu; Jianquan Chen; Huiqing Yu; Juan Chen; Xujun Xu; Youbing Wu; Aimin Zhang; Guoxiang Cheng
Journal:  Transgenic Res       Date:  2008-09-24       Impact factor: 2.788

9.  Is there a risk from not using GE animals?

Authors:  James D Murray; Elizabeth A Maga
Journal:  Transgenic Res       Date:  2009-11-04       Impact factor: 2.788

10.  Evaluating the fitness of human lysozyme transgenic dairy goats: growth and reproductive traits.

Authors:  Kathryn A Jackson; Jolene M Berg; James D Murray; Elizabeth A Maga
Journal:  Transgenic Res       Date:  2010-02-05       Impact factor: 2.788

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.